Artikelen met mandaten voor openbare toegang - Richard WJ GroenMeer informatie
Nergens beschikbaar: 1
Bone marrow mesenchymal stromal cells can render multiple myeloma cells resistant to cytotoxic machinery of CAR T cells through inhibition of apoptosis
LC Holthof, JJ van der Schans, A Katsarou, R Poels, AT Gelderloos, ...
Clinical Cancer Research 27 (13), 3793-3803, 2021
Mandaten: Worldwide Cancer Research, UK, KWF Kankerbestrijding
Ergens beschikbaar: 30
Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia
A Gutierrez, L Pan, RWJ Groen, F Baleydier, A Kentsis, J Marineau, ...
The Journal of clinical investigation 124 (2), 644-655, 2014
Mandaten: US National Institutes of Health, National Institute of Health and Medical …
Monocytes and granulocytes reduce CD38 expression levels on myeloma cells in patients treated with daratumumab
J Krejcik, KA Frerichs, IS Nijhof, B van Kessel, JF van Velzen, AC Bloem, ...
Clinical cancer research 23 (24), 7498-7511, 2017
Mandaten: US National Institutes of Health
Combined CD28 and 4-1BB costimulation potentiates affinity-tuned chimeric antigen receptor–engineered T cells
E Drent, R Poels, R Ruiter, NWCJ van de Donk, S Zweegman, H Yuan, ...
Clinical Cancer Research 25 (13), 4014-4025, 2019
Mandaten: US National Institutes of Health
Non-canonical PRC1. 1 targets active genes independent of H3K27me3 and is essential for leukemogenesis
V van den Boom, H Maat, M Geugien, AR López, AM Sotoca, J Jaques, ...
Cell reports 14 (2), 332-346, 2016
Mandaten: Nederlandse Organisatie voor Wetenschappelijk Onderzoek, European Commission …
Establishing human leukemia xenograft mouse models by implanting human bone marrow–like scaffold-based niches
A Antonelli, WA Noort, J Jaques, B de Boer, R de Jong-Korlaar, ...
Blood, The Journal of the American Society of Hematology 128 (25), 2949-2959, 2016
Mandaten: European Commission, KWF Kankerbestrijding
Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease
A Garcia-Gomez, D Quwaider, M Canavese, EM Ocio, Z Tian, JF Blanco, ...
Clinical cancer research 20 (6), 1542-1554, 2014
Mandaten: Government of Spain
Functional genomics identify distinct and overlapping genes mediating resistance to different classes of heterobifunctional degraders of oncoproteins
R Shirasaki, GM Matthews, S Gandolfi, R de Matos Simoes, DL Buckley, ...
Cell Reports 34 (1), 2021
Mandaten: US Department of Defense, US National Institutes of Health, AIRC Foundation …
Accessory cells of the microenvironment protect multiple myeloma from T-cell cytotoxicity through cell adhesion-mediated immune resistance
SJ de Haart, NWCJ van de Donk, MC Minnema, JH Huang, ...
Clinical cancer research 19 (20), 5591-5601, 2013
Mandaten: US National Institutes of Health, KWF Kankerbestrijding
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence
A Katsarou, M Sjöstrand, J Naik, J Mansilla-Soto, D Kefala, G Kladis, ...
Science translational medicine 13 (623), eabh1962, 2021
Mandaten: US National Institutes of Health, Swedish Research Council
N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation
RWJ Groen, MFM de Rooij, KA Kocemba, RM Reijmers, ...
Haematologica 96 (11), 1653, 2011
Mandaten: US National Institutes of Health
PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation
Z Ren, JH Ahn, H Liu, YH Tsai, NV Bhanu, B Koss, DF Allison, A Ma, ...
Blood, The Journal of the American Society of Hematology 134 (14), 1176-1189, 2019
Mandaten: US Department of Defense, US National Institutes of Health
Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival
RM Reijmers, RWJ Groen, A Kuil, K Weijer, FC Kimberley, JP Medema, ...
Blood, The Journal of the American Society of Hematology 117 (23), 6162-6171, 2011
Mandaten: Swedish Research Council
Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
S Sarkar, M van Gelder, W Noort, Y Xu, KMA Rouschop, R Groen, ...
Cancer Immunology, Immunotherapy 64, 951-963, 2015
Mandaten: US National Institutes of Health, KWF Kankerbestrijding
Illegitimate WNT pathway activation by β-catenin mutation or autocrine stimulation in T-cell malignancies
RWJ Groen, MECM Oud, EJM Schilder-Tol, MB Overdijk, D ten Berge, ...
Cancer research 68 (17), 6969-6977, 2008
Mandaten: Howard Hughes Medical Institute
Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model
P Sontakke, M Carretta, J Jaques, AZ Brouwers-Vos, L Lubbers-Aalders, ...
Leukemia 30 (10), 2064-2073, 2016
Mandaten: European Commission, KWF Kankerbestrijding
Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance
SJ de Haart, L Holthof, WA Noort, MC Minnema, ME Emmelot, ...
Haematologica 101 (8), e339, 2016
Mandaten: Worldwide Cancer Research, UK, KWF Kankerbestrijding
Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma
AK Deshantri, MH Fens, RWJ Ruiter, JM Metselaar, G Storm, L van Bloois, ...
Journal of controlled release 296, 232-240, 2019
Mandaten: Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma
D Cholujova, Z Bujnakova, E Dutkova, T Hideshima, RW Groen, ...
British journal of haematology 179 (5), 756-771, 2017
Mandaten: US National Institutes of Health, European Commission
A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response
R Lameris, A Shahine, DG Pellicci, AP Uldrich, S Gras, J Le Nours, ...
Nature Cancer 1 (11), 1054-1065, 2020
Mandaten: US National Institutes of Health, Australian Research Council, National …
Publicatie- en financieringsgegevens worden automatisch vastgesteld door een computerprogramma